A Long-term, Continued Treatment and Follow-up Study in Participants With Hematologic Malignancies Treated With Duvelisib (IPI-145)

Clinical trial NCT02711852 · COMPLETED

Trial details

NCT number: NCT02711852
Sponsor: SecuraBio
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hematologic Malignancy

Start date: 2016-04-01
Primary completion: 2020-05-04
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.